Domenico Accili - Publications

Affiliations: 
Columbia University, New York, NY 
Area:
Biomedical Engineering
Website:
https://www.gsas.cuimc.columbia.edu/profile/domenico-accili-md

217 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Accili D, Talchai SC, Bouchi R, Lee AY, Du W, Kitamoto T, McKimpson WM, Belvedere S, Lin HV. Diabetes treatment by conversion of gut epithelial cells to insulin-producing cells. Journal of Diabetes Investigation. PMID 38426644 DOI: 10.1111/jdi.14175  0.5
2024 Watanabe H, Asahara SI, Son J, McKimpson WM, de Cabo R, Accili D. Cyb5r3 activation rescues secondary failure to sulfonylurea but not β-cell dedifferentiation. Plos One. 19: e0297555. PMID 38335173 DOI: 10.1371/journal.pone.0297555  0.388
2024 Suda N, Bartolomé A, Liang J, Son J, Yagishita Y, Siebel C, Accili D, Ding H, Pajvani UB. β-cell Jagged1 is sufficient but not necessary for islet Notch activity and insulin secretory defects in obese mice. Molecular Metabolism. 81: 101894. PMID 38311286 DOI: 10.1016/j.molmet.2024.101894  0.352
2023 Pajvani UB, Shawber CJ, Samuel VT, Birkenfeld AL, Shulman GI, Kitajewski J, Accili D. Author Correction: Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nature Medicine. PMID 38041001 DOI: 10.1038/s41591-023-02695-9  0.359
2023 Park J, Hall C, Hubbard B, LaMoia T, Gaspar R, Nasiri A, Li F, Zhang H, Kim J, Haeusler RA, Accili D, Shulman GI, Yu H, Choi E. MAD2-dependent insulin receptor endocytosis regulates metabolic homeostasis. Diabetes. PMID 37725942 DOI: 10.2337/db23-0314  0.486
2023 Son J, Accili D. Reversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes. Experimental & Molecular Medicine. 55: 1652-1658. PMID 37524865 DOI: 10.1038/s12276-023-01043-8  0.402
2023 Kitamoto T, Accili D. Unraveling the mysteries of hepatic insulin signaling: deconvoluting the nuclear targets of insulin. Endocrine Journal. PMID 37245960 DOI: 10.1507/endocrj.EJ23-0150  0.491
2023 Son J, Du W, Esposito M, Shariati K, Ding H, Kang Y, Accili D. Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure. Nature Communications. 14: 558. PMID 36732513 DOI: 10.1038/s41467-023-36315-4  0.312
2023 Watanabe H, Du W, Son J, Sui L, Asahara SI, Kurland IJ, Kuo T, Kitamoto T, Miyachi Y, de Cabo R, Accili D. Cyb5r3-based mechanism and reversal of secondary failure to sulfonylurea in diabetes. Science Translational Medicine. 15: eabq4126. PMID 36724243 DOI: 10.1126/scitranslmed.abq4126  0.367
2022 Accili D, Du W, Kitamoto T, Kuo T, McKimpson W, Miyachi Y, Mukhanova M, Son J, Wang L, Watanabe H. Reflections on the state of diabetes research and prospects for treatment. Diabetology International. 14: 21-31. PMID 36636157 DOI: 10.1007/s13340-022-00600-2  0.354
2022 Kitamoto T, Lee YK, Sultana N, Watanabe H, M WM, Du W, Fan J, Diaz B, Lin HV, Leibel RL, Belvedere S, Accili D. Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes. Molecular Metabolism. 101624. PMID 36341906 DOI: 10.1016/j.molmet.2022.101624  0.419
2022 Lee YK, Du W, Nie Y, Diaz B, Sultana N, Kitamoto T, Leibel RL, Accili D, Belvedere S. Single-agent FOXO1 inhibition normalizes glycemia and induces gut β-like cells in streptozotocin-diabetic mice. Molecular Metabolism. 101618. PMID 36283677 DOI: 10.1016/j.molmet.2022.101618  0.476
2022 Du W, Wang J, Kuo T, Wang L, McKimpson WM, Son J, Watanabe H, Kitamoto T, Lee YK, Creusot RJ, Ratner LE, McCune K, Chen YW, Grubbs BH, Thornton ME, ... ... Accili D, et al. Pharmacological conversion of gut epithelial cells into insulin-producing cells lowers glycemia in diabetic animals. The Journal of Clinical Investigation. PMID 36282594 DOI: 10.1172/JCI162720  0.505
2022 Sasako T, Umehara T, Soeda K, Kaneko K, Suzuki M, Kobayashi N, Okazaki Y, Tamura-Nakano M, Chiba T, Accili D, Kahn CR, Noda T, Asahara H, Yamauchi T, Kadowaki T, et al. Deletion of skeletal muscle Akt1/2 causes osteosarcopenia and reduces lifespan in mice. Nature Communications. 13: 5655. PMID 36198696 DOI: 10.1038/s41467-022-33008-2  0.378
2022 Park J, Li J, Mayer JP, Ball KA, Wu J, Hall C, Accili D, Stowell MHB, Bai XC, Choi E. Activation of the insulin receptor by an insulin mimetic peptide. Nature Communications. 13: 5594. PMID 36151101 DOI: 10.1038/s41467-022-33274-0  0.445
2022 McKimpson WM, Kuo T, Kitamoto T, Higuchi S, Mills JC, Haeusler RA, Accili D. FOXO1 Is Present in Stomach Epithelium and Determines Gastric Cell Distribution. Gastro Hep Advances. 1: 733-745. PMID 36117550 DOI: 10.1016/j.gastha.2022.05.005  0.387
2022 Bartolomé A, Suda N, Yu J, Zhu C, Son J, Ding H, Califano A, Accili D, Pajvani UB. Notch-mediated Ephrin signaling disrupts islet architecture and β cell function. Jci Insight. PMID 35167496 DOI: 10.1172/jci.insight.157694  0.371
2021 Wang L, Yu J, Zhou Q, Wang X, Mukhanova M, Du W, Sun L, Pajvani UB, Accili D. TOX4, an insulin receptor-independent regulator of hepatic glucose production, is activated in diabetic liver. Cell Metabolism. PMID 34914893 DOI: 10.1016/j.cmet.2021.11.013  0.473
2021 Son J, Ding H, Farb TB, Efanov AM, Sun J, Gore JL, Syed SK, Lei Z, Wang Q, Accili D, Califano A. BACH2 inhibition reverses β cell failure in type 2 diabetes models. The Journal of Clinical Investigation. 131. PMID 34907913 DOI: 10.1172/JCI153876  0.481
2021 Miyachi Y, Kuo T, Son J, Accili D. Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. Plos One. 16: e0260526. PMID 34843575 DOI: 10.1371/journal.pone.0260526  0.398
2021 Kitamoto T, Kuo T, Okabe A, Kaneda A, Accili D. An integrative transcriptional logic model of hepatic insulin resistance. Proceedings of the National Academy of Sciences of the United States of America. 118. PMID 34732569 DOI: 10.1073/pnas.2102222118  0.46
2021 Lambie M, Bonomini M, Davies SJ, Accili D, Arduini A, Zammit V. Insulin resistance in cardiovascular disease, uremia, and peritoneal dialysis. Trends in Endocrinology and Metabolism: Tem. PMID 34266706 DOI: 10.1016/j.tem.2021.06.001  0.349
2021 Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, Der-Nigoghossian C, Liyanage-Don N, ... ... Accili D, et al. Post-acute COVID-19 syndrome. Nature Medicine. PMID 33753937 DOI: 10.1038/s41591-021-01283-z  0.67
2021 Lee YK, Diaz B, Deroose M, Lee SX, Belvedere S, Accili D, Leibel RL, Lin HV. FOXO1 inhibition synergizes with FGF21 to normalize glucose control in diabetic mice. Molecular Metabolism. 101187. PMID 33577983 DOI: 10.1016/j.molmet.2021.101187  0.314
2020 Toda G, Soeda K, Okazaki Y, Kobayashi N, Masuda Y, Arakawa N, Suwanai H, Masamoto Y, Izumida Y, Kamei N, Sasako T, Suzuki R, Kubota T, Kubota N, Kurokawa M, ... ... Accili D, et al. Insulin- and Lipopolysaccharide-Mediated Signaling in Adipose Tissue Macrophages Regulates Postprandial Glycemia through Akt-mTOR Activation. Molecular Cell. PMID 32464093 DOI: 10.1016/J.Molcel.2020.04.033  0.523
2020 Liu L, Fan L, Chan M, Kraakman MJ, Yang J, Fan Y, Aaron N, Wan Q, Carrillo-Sepulveda MA, Tall AR, Tabas I, Accili D, Qiang L. PPARγ Deacetylation Confers the Anti-Atherogenic Effect and Improves Endothelial Function in Diabetes Treatment. Diabetes. PMID 32409492 DOI: 10.2337/Db20-0217  0.452
2020 Hosooka T, Hosokawa Y, Matsugi K, Shinohara M, Senga Y, Tamori Y, Aoki C, Matsui S, Sasaki T, Kitamura T, Kuroda M, Sakaue H, Nomura K, Yoshino K, Nabatame Y, ... ... Accili D, et al. The PDK1-FoxO1 signaling in adipocytes controls systemic insulin sensitivity through the 5-lipoxygenase-leukotriene B axis. Proceedings of the National Academy of Sciences of the United States of America. PMID 32393635 DOI: 10.1073/Pnas.1921015117  0.544
2020 Fan J, Du W, Kim-Muller JY, Son J, Kuo T, Larrea D, Garcia C, Kitamoto T, Kraakman MJ, Owusu-Ansah E, Cirulli V, Accili D. Cyb5r3 links FoxO1-dependent mitochondrial dysfunction with β-cell failure. Molecular Metabolism. 34: 97-111. PMID 32180563 DOI: 10.1016/J.Molmet.2019.12.008  0.354
2020 Kuo T, Accili D. 2071-P: C2CD4A, Pancreatic Beta-Cell Function, and Type 2 Diabetes Susceptibility Diabetes. 69. DOI: 10.2337/Db20-2071-P  0.366
2020 McKimpson WM, Kuo T, Kitamoto T, Higuchi S, Haeusler R, Accili D. SUN-646 A Novel Population of FOXO1-Expressing Cells in the Stomach Controls Cell Plasticity by Regulating the Cyclin CCNE1 Journal of the Endocrine Society. 4. DOI: 10.1210/Jendso/Bvaa046.528  0.496
2019 Kuo T, Kraakman MJ, Damle M, Gill R, Lazar MA, Accili D. Identification of as a human diabetes susceptibility gene with a role in β cell insulin secretion. Proceedings of the National Academy of Sciences of the United States of America. PMID 31527256 DOI: 10.1073/Pnas.1904311116  0.458
2019 Ren H, Vieira-de-Abreu A, Yan S, Reilly AM, Chan O, Accili D. Altered Central Nutrient Sensing in Male Mice Lacking Insulin Receptors in Glut4-expressing Neurons. Endocrinology. PMID 31199472 DOI: 10.1210/En.2019-00341  0.496
2019 McKimpson WM, Accili D. Reprogramming Cells to Make Insulin. Journal of the Endocrine Society. 3: 1214-1226. PMID 31187080 DOI: 10.1210/Js.2019-00040  0.569
2019 Kuo T, Damle M, González BJ, Egli D, Lazar MA, Accili D. Induction of α cell-restricted Gc in dedifferentiating β cells contributes to stress-induced β-cell dysfunction. Jci Insight. 5. PMID 31120862 DOI: 10.1172/Jci.Insight.128351  0.45
2019 McKimpson WM, Accili D. A Fluorescent Reporter Assay of Differential Gene Expression Response to Insulin in Hepatocytes. American Journal of Physiology. Cell Physiology. PMID 31091147 DOI: 10.1152/Ajpcell.00504.2018  0.542
2019 Wang L, Liu Q, Kitamoto T, Hou J, Qin J, Accili D. Identification of Insulin-Responsive Transcription Factors Regulating Hepatocyte Glucose Production. Diabetes. PMID 30936148 DOI: 10.2337/Db18-1236  0.546
2018 Langlet F, Tarbier M, Haeusler RA, Camastra S, Ferrannini E, Friedländer MR, Accili D. microRNA-205-5p is a modulator of insulin sensitivity that inhibits FOXO function. Molecular Metabolism. PMID 30174230 DOI: 10.1016/J.Molmet.2018.08.003  0.548
2018 Accili D. Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture. Diabetes. 67: 1701-1709. PMID 30135131 DOI: 10.2337/Dbi18-0025  0.557
2018 Kitamoto T, Sakurai K, Lee EY, Yokote K, Accili D, Miki T. Distinct roles of systemic and local actions of insulin on pancreatic β-cells. Metabolism: Clinical and Experimental. PMID 29320716 DOI: 10.1016/J.Metabol.2017.12.017  0.415
2018 MCKIMPSON W, KUO T, ACCILI D. Foxo1-Expressing Cells in the Gut as a Source of Insulin for Diabetes Treatment Diabetes. 67: 324-OR. DOI: 10.2337/Db18-324-Or  0.529
2018 CINTI F, SEVERI I, SULEIMAN M, MARSELLI L, MARCHETTI P, CINTI S, ACCILI D. The Increment of Noradrenergic Fibers Correlates with the Density of Dedifferentiated ß Cells in Humans Diabetes. 67: 2142-P. DOI: 10.2337/Db18-2142-P  0.359
2017 Caruso M, Miele C, Oliva A, Condorelli G, Oriente F, Riccardi G, Capaldo B, Fiory F, Accili D, Formisano P, Beguinot F. Expression of Concern. The IR1152 Mutant Insulin Receptor Selectively Impairs Insulin Action in Skeletal Muscle but Not in Liver. Diabetes 2000;49:1194-1202. DOI: https://doi.org/10.2337/diabetes.49.7.1194. PMID: 10909978. Diabetes. PMID 29109243 DOI: 10.2337/Db17-Ec2017A  0.42
2017 Langlet F, Haeusler RA, Lindén D, Ericson E, Norris T, Johansson A, Cook JR, Aizawa K, Wang L, Buettner C, Accili D. Selective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling. Cell. PMID 29056338 DOI: 10.1016/J.Cell.2017.09.045  0.805
2017 Haeusler RA, McGraw TE, Accili D. Biochemical and cellular properties of insulin receptor signalling. Nature Reviews. Molecular Cell Biology. PMID 28974775 DOI: 10.1038/Nrm.2017.89  0.585
2017 Ishida E, Kim-Muller JY, Accili D. Pair-Feeding, but not Insulin, Phloridzin, or Rosiglitazone Treatment Curtails Markers of Beta-cell Dedifferentiation in db/db Mice. Diabetes. PMID 28506962 DOI: 10.2337/Db16-1213  0.524
2016 Accili D, Talchai SC, Kim-Muller JY, Cinti F, Ishida E, Ordelheide AM, Kuo T, Fan J, Son J. When β-cells fail: lessons from dedifferentiation. Diabetes, Obesity & Metabolism. 18: 117-22. PMID 27615140 DOI: 10.1111/Dom.12723  0.482
2016 Kim-Muller JY, Fan J, Kim YJ, Lee SA, Ishida E, Blaner WS, Accili D. Aldehyde dehydrogenase 1a3 defines a subset of failing pancreatic β cells in diabetic mice. Nature Communications. 7: 12631. PMID 27572106 DOI: 10.1038/Ncomms12631  0.476
2016 O'Neill BT, Lee KY, Klaus K, Softic S, Krumpoch MT, Fentz J, Stanford KI, Robinson MM, Cai W, Kleinridders A, Pereira RO, Hirshman MF, Abel ED, Accili D, Goodyear LJ, et al. Insulin and IGF-1 receptors regulate FoxO-mediated signaling in muscle proteostasis. The Journal of Clinical Investigation. PMID 27525440 DOI: 10.1172/Jci86522  0.368
2016 Vazirani RP, Verma A, Sadacca LA, Buckman MS, Picatoste B, Beg M, Torsitano C, Bruno JH, Patel RT, Simonyte K, Camporez JP, Moreira G, Falcone DJ, Accili D, Elemento O, et al. Disruption of Adipose Rab10-Dependent Insulin Signaling Causes Hepatic Insulin Resistance. Diabetes. PMID 27207531 DOI: 10.2337/db15-1128  0.465
2016 Kim-Muller JY, Kim YJ, Fan J, Zhao S, Banks AS, Prentki M, Accili D. FoxO1 Deacetylation Decreases Fatty Acid Oxidation in beta-cells and Sustains Insulin Secretion in Diabetes. The Journal of Biological Chemistry. PMID 26984405 DOI: 10.1074/Jbc.M115.705608  0.47
2016 Kuo T, Kim-Muller JY, McGraw TE, Accili D. Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic β Cell Dysfunction. The Journal of Biological Chemistry. PMID 26917725 DOI: 10.1074/Jbc.M115.702183  0.544
2016 Cinti F, Bouchi R, Kim-Muller JY, Ohmura Y, Sandoval PR, Masini M, Marselli L, Suleiman M, Ratner LE, Marchetti P, Accili D. Evidence of β-Cell Dedifferentiation in Human Type 2 Diabetes. The Journal of Clinical Endocrinology and Metabolism. 101: 1044-54. PMID 26713822 DOI: 10.1210/Jc.2015-2860  0.449
2015 Abraham A, Rubin M, Accili D, Bilezikian JP, Pajvani UB. Hypoglycemia Secondary to Sulfonylurea Ingestion in a Patient with End Stage Renal Disease: Results from a 72-Hour Fast. Case Reports in Endocrinology. 2015: 742781. PMID 26664768 DOI: 10.1155/2015/742781  0.425
2015 Pajvani UB, Accili D. The new biology of diabetes. Diabetologia. 58: 2459-68. PMID 26248647 DOI: 10.1007/s00125-015-3722-5  0.415
2015 Ren H, Cook JR, Kon N, Accili D. Gpr17 in AgRP Neurons Regulates Feeding and Sensitivity to Insulin and Leptin. Diabetes. 64: 3670-9. PMID 26180086 DOI: 10.2337/Db15-0390  0.768
2015 Qiang L, Kon N, Zhao W, Jiang L, Knight CM, Welch C, Pajvani U, Gu W, Accili D. Hepatic SirT1-Dependent Gain of Function of Stearoyl-CoA Desaturase-1 Conveys Dysmetabolic and Tumor Progression Functions. Cell Reports. 11: 1797-808. PMID 26074075 DOI: 10.1016/J.Celrep.2015.05.025  0.337
2015 Mayoral R, Osborn O, McNelis J, Johnson AM, Oh da Y, Izquierdo CL, Chung H, Li P, Traves PG, Bandyopadhyay G, Pessentheiner AR, Ofrecio JM, Cook JR, Qiang L, Accili D, et al. Adipocyte SIRT1 knockout promotes PPARγ activity, adipogenesis and insulin sensitivity in chronic-HFD and obesity. Molecular Metabolism. 4: 378-91. PMID 25973386 DOI: 10.1016/J.Molmet.2015.02.007  0.754
2015 Cook JR, Langlet F, Kido Y, Accili D. Pathogenesis of selective insulin resistance in isolated hepatocytes. The Journal of Biological Chemistry. 290: 13972-80. PMID 25873396 DOI: 10.1074/Jbc.M115.638197  0.815
2015 Talchai SC, Accili D. Legacy Effect of Foxo1 in Pancreatic Endocrine Progenitors on Adult β-Cell Mass and Function. Diabetes. 64: 2868-79. PMID 25784544 DOI: 10.2337/Db14-1696  0.425
2015 Cook JR, Matsumoto M, Banks AS, Kitamura T, Tsuchiya K, Accili D. A Mutant Allele Encoding DNA Binding-Deficient FoxO1 Differentially Regulates Hepatic Glucose and Lipid Metabolism. Diabetes. 64: 1951-65. PMID 25576059 DOI: 10.2337/Db14-1506  0.785
2015 Ren H, Lu TY, McGraw TE, Accili D. Anorexia and impaired glucose metabolism in mice with hypothalamic ablation of Glut4 neurons. Diabetes. 64: 405-17. PMID 25187366 DOI: 10.2337/Db14-0752  0.439
2014 Haeusler RA, Hartil K, Vaitheesvaran B, Arrieta-Cruz I, Knight CM, Cook JR, Kammoun HL, Febbraio MA, Gutierrez-Juarez R, Kurland IJ, Accili D. Integrated control of hepatic lipogenesis versus glucose production requires FoxO transcription factors. Nature Communications. 5: 5190. PMID 25307742 DOI: 10.1038/Ncomms6190  0.798
2014 Kim-Muller JY, Zhao S, Srivastava S, Mugabo Y, Noh HL, Kim YR, Madiraju SR, Ferrante AW, Skolnik EY, Prentki M, Accili D. Metabolic inflexibility impairs insulin secretion and results in MODY-like diabetes in triple FoxO-deficient mice. Cell Metabolism. 20: 593-602. PMID 25264246 DOI: 10.1016/J.Cmet.2014.08.012  0.51
2014 Bouchi R, Foo KS, Hua H, Tsuchiya K, Ohmura Y, Sandoval PR, Ratner LE, Egli D, Leibel RL, Accili D. FOXO1 inhibition yields functional insulin-producing cells in human gut organoid cultures. Nature Communications. 5: 4242. PMID 24979718 DOI: 10.1038/Ncomms5242  0.557
2014 Ren H, Yan S, Zhang B, Lu TY, Arancio O, Accili D. Glut4 expression defines an insulin-sensitive hypothalamic neuronal population. Molecular Metabolism. 3: 452-9. PMID 24944904 DOI: 10.1016/J.Molmet.2014.04.006  0.484
2014 Heinrich G, Meece K, Wardlaw SL, Accili D. Preserved energy balance in mice lacking FoxO1 in neurons of Nkx2.1 lineage reveals functional heterogeneity of FoxO1 signaling within the hypothalamus. Diabetes. 63: 1572-82. PMID 24487022 DOI: 10.2337/Db13-0651  0.329
2014 Giannulis I, Mondini E, Cinti F, Frontini A, Murano I, Barazzoni R, Barbatelli G, Accili D, Cinti S. Increased density of inhibitory noradrenergic parenchymal nerve fibers in hypertrophic islets of Langerhans of obese mice. Nutrition Metabolism and Cardiovascular Diseases. 24: 384-392. PMID 24462047 DOI: 10.1016/J.Numecd.2013.09.006  0.49
2013 Haeusler RA, Astiarraga B, Camastra S, Accili D, Ferrannini E. Human insulin resistance is associated with increased plasma levels of 12α-hydroxylated bile acids. Diabetes. 62: 4184-91. PMID 23884887 DOI: 10.2337/Db13-0639  0.486
2013 Ren H, Plum-Morschel L, Gutierrez-Juarez R, Lu TY, Kim-Muller JY, Heinrich G, Wardlaw SL, Silver R, Accili D. Blunted refeeding response and increased locomotor activity in mice lacking FoxO1 in synapsin-Cre-expressing neurons. Diabetes. 62: 3373-83. PMID 23835335 DOI: 10.2337/Db13-0597  0.382
2013 Pajvani UB, Qiang L, Kangsamaksin T, Kitajewski J, Ginsberg HN, Accili D. Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nature Medicine. 19: 1054-60. PMID 23832089 DOI: 10.1038/Nm.3259  0.375
2013 Kurland IJ, Accili D, Burant C, Fischer SM, Kahn BB, Newgard CB, Ramagiri S, Ronnett GV, Ryals JA, Sanders M, Shambaugh J, Shockcor J, Gross SS. Application of combined omics platforms to accelerate biomedical discovery in diabesity. Annals of the New York Academy of Sciences. 1287: 1-16. PMID 23659636 DOI: 10.1111/Nyas.12116  0.312
2013 Tsuchiya K, Westerterp M, Murphy AJ, Subramanian V, Ferrante AW, Tall AR, Accili D. Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice. Circulation Research. 112: 992-1003. PMID 23420833 DOI: 10.1161/Circresaha.112.300749  0.409
2013 Fiorentino L, Cavalera M, Menini S, Marchetti V, Mavilio M, Fabrizi M, Conserva F, Casagrande V, Menghini R, Pontrelli P, Arisi I, D'Onofrio M, Lauro D, Khokha R, Accili D, et al. Loss of TIMP3 underlies diabetic nephropathy via FoxO1/STAT1 interplay. Embo Molecular Medicine. 5: 441-55. PMID 23401241 DOI: 10.1002/Emmm.201201475  0.356
2013 Tsuchiya K, Accili D. Liver sinusoidal endothelial cells link hyperinsulinemia to hepatic insulin resistance. Diabetes. 62: 1478-89. PMID 23349480 DOI: 10.2337/Db12-1296  0.568
2012 Ido-Kitamura Y, Sasaki T, Kobayashi M, Kim HJ, Lee YS, Kikuchi O, Yokota-Hashimoto H, Iizuka K, Accili D, Kitamura T. Hepatic FoxO1 integrates glucose utilization and lipid synthesis through regulation of Chrebp O-glycosylation. Plos One. 7: e47231. PMID 23056614 DOI: 10.1371/Journal.Pone.0047231  0.461
2012 Talchai C, Xuan S, Lin HV, Sussel L, Accili D. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure. Cell. 150: 1223-34. PMID 22980982 DOI: 10.1016/J.Cell.2012.07.029  0.728
2012 Boitard C, Accili D, Ahrén B, Cerasi E, Seino S, Thorens B. The hyperstimulated β-cell: prelude to diabetes? Diabetes, Obesity & Metabolism. 14: iv-viii. PMID 22928578 DOI: 10.1111/J.1463-1326.2012.01693.X  0.37
2012 Qiang L, Wang L, Kon N, Zhao W, Lee S, Zhang Y, Rosenbaum M, Zhao Y, Gu W, Farmer SR, Accili D. Brown remodeling of white adipose tissue by SirT1-dependent deacetylation of Pparγ. Cell. 150: 620-32. PMID 22863012 DOI: 10.1016/J.Cell.2012.06.027  0.369
2012 Ozcan L, Wong CC, Li G, Xu T, Pajvani U, Park SK, Wronska A, Chen BX, Marks AR, Fukamizu A, Backs J, Singer HA, Yates JR, Accili D, Tabas I. Calcium signaling through CaMKII regulates hepatic glucose production in fasting and obesity. Cell Metabolism. 15: 739-51. PMID 22503562 DOI: 10.1016/J.Cmet.2012.03.002  0.411
2012 Ai D, Chen C, Han S, Ganda A, Murphy AJ, Haeusler R, Thorp E, Accili D, Horton JD, Tall AR. Regulation of hepatic LDL receptors by mTORC1 and PCSK9 in mice. The Journal of Clinical Investigation. 122: 1262-70. PMID 22426206 DOI: 10.1172/Jci61919  0.433
2012 Talchai C, Xuan S, Kitamura T, DePinho RA, Accili D. Generation of functional insulin-producing cells in the gut by Foxo1 ablation. Nature Genetics. 44: 406-12, S1. PMID 22406641 DOI: 10.1038/Ng.2215  0.809
2012 Tsuchiya K, Tanaka J, Shuiqing Y, Welch CL, DePinho RA, Tabas I, Tall AR, Goldberg IJ, Accili D. FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metabolism. 15: 372-81. PMID 22405072 DOI: 10.1016/J.Cmet.2012.01.018  0.51
2012 Qiang L, Tsuchiya K, Kim-Muller JY, Lin HV, Welch C, Accili D. Increased atherosclerosis and endothelial dysfunction in mice bearing constitutively deacetylated alleles of Foxo1 gene. The Journal of Biological Chemistry. 287: 13944-51. PMID 22389493 DOI: 10.1074/Jbc.M111.332767  0.428
2012 Qiang L, Accili D. FGF21 and the second coming of PPARγ. Cell. 148: 397-8. PMID 22304910 DOI: 10.1016/J.Cell.2012.01.020  0.335
2012 Haeusler RA, Pratt-Hyatt M, Welch CL, Klaassen CD, Accili D. Impaired generation of 12-hydroxylated bile acids links hepatic insulin signaling with dyslipidemia. Cell Metabolism. 15: 65-74. PMID 22197325 DOI: 10.1016/J.Cmet.2011.11.010  0.443
2012 Kon N, Zhong J, Qiang L, Accili D, Gu W. Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice. The Journal of Biological Chemistry. 287: 5102-11. PMID 22187431 DOI: 10.1074/Jbc.M111.322867  0.351
2012 Accili D. Insulin receptor knock-out mice. Trends in Endocrinology and Metabolism: Tem. 8: 101-4. PMID 18406794 DOI: 10.1016/S1043-2760(97)00031-3  0.47
2012 Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Pietropaolo M, Arvan PR, Von Herrath M, Markel DS, Rhodes CJ. How does type 1 diabetes develop? The notion of homicide or β-cell suicide revisited (Diabetes (2011) 60, (1370-1379)) Diabetes. 61: 1648. DOI: 10.2337/Db12-Er06A  0.384
2011 Qiang L, Lin HV, Kim-Muller JY, Welch CL, Gu W, Accili D. Proatherogenic abnormalities of lipid metabolism in SirT1 transgenic mice are mediated through Creb deacetylation. Cell Metabolism. 14: 758-67. PMID 22078933 DOI: 10.1016/J.Cmet.2011.10.007  0.519
2011 Banks AS, Kim-Muller JY, Mastracci TL, Kofler NM, Qiang L, Haeusler RA, Jurczak MJ, Laznik D, Heinrich G, Samuel VT, Shulman GI, Papaioannou VE, Accili D. Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice. Cell Metabolism. 14: 587-97. PMID 22055502 DOI: 10.1016/J.Cmet.2011.09.012  0.514
2011 Tsuchiya K, Banks AS, Liang CP, Tabas I, Tall AR, Accili D. Homozygosity for an allele encoding deacetylated FoxO1 protects macrophages from cholesterol-induced inflammation without increasing apoptosis. Arteriosclerosis, Thrombosis, and Vascular Biology. 31: 2920-8. PMID 21940942 DOI: 10.1161/Atvbaha.110.219477  0.347
2011 Tsunekawa S, Demozay D, Briaud I, McCuaig J, Accili D, Stein R, Rhodes CJ. FoxO feedback control of basal IRS-2 expression in pancreatic β-cells is distinct from that in hepatocytes. Diabetes. 60: 2883-91. PMID 21933986 DOI: 10.2337/Db11-0340  0.499
2011 Pajvani UB, Shawber CJ, Samuel VT, Birkenfeld AL, Shulman GI, Kitajewski J, Accili D. Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner. Nature Medicine. 17: 961-7. PMID 21804540 DOI: 10.1038/Nm.2378  0.578
2011 Lin HV, Accili D. Hormonal regulation of hepatic glucose production in health and disease. Cell Metabolism. 14: 9-19. PMID 21723500 DOI: 10.1016/J.Cmet.2011.06.003  0.429
2011 Gonzalez E, Flier E, Molle D, Accili D, McGraw TE. Hyperinsulinemia leads to uncoupled insulin regulation of the GLUT4 glucose transporter and the FoxO1 transcription factor. Proceedings of the National Academy of Sciences of the United States of America. 108: 10162-7. PMID 21646544 DOI: 10.1073/Pnas.1019268108  0.574
2011 Atkinson MA, Bluestone JA, Eisenbarth GS, Hebrok M, Herold KC, Accili D, Pietropaolo M, Arvan PR, Von Herrath M, Markel DS, Rhodes CJ. How does type 1 diabetes develop?: the notion of homicide or β-cell suicide revisited. Diabetes. 60: 1370-9. PMID 21525508 DOI: 10.2337/Db10-1797  0.396
2011 Kim-Muller JY, Accili D. Cell biology. Selective insulin sensitizers. Science (New York, N.Y.). 331: 1529-31. PMID 21436429 DOI: 10.1126/Science.1204504  0.578
2011 Lin HV, Ren H, Samuel VT, Lee HY, Lu TY, Shulman GI, Accili D. Diabetes in mice with selective impairment of insulin action in Glut4-expressing tissues. Diabetes. 60: 700-9. PMID 21266328 DOI: 10.2337/Db10-1056  0.57
2011 Lin HV, Accili D. Reconstitution of insulin action in muscle, white adipose tissue, and brain of insulin receptor knock-out mice fails to rescue diabetes. The Journal of Biological Chemistry. 286: 9797-804. PMID 21239487 DOI: 10.1074/Jbc.M110.210807  0.589
2011 Accili D, Ahrén B, Boitard C, Cerasi E, Henquin JC, Seino S. What ails the β-cell? Diabetes, Obesity & Metabolism. 1-3. PMID 21029293 DOI: 10.1111/J.1463-1326.2010.01296.X  0.305
2011 Carmody JS, Wan P, Accili D, Zeltser LM, Leibel RL. Respective contributions of maternal insulin resistance and diet to metabolic and hypothalamic phenotypes of progeny. Obesity (Silver Spring, Md.). 19: 492-9. PMID 20948526 DOI: 10.1038/Oby.2010.245  0.408
2010 Xuan S, Szabolcs M, Cinti F, Perincheri S, Accili D, Efstratiadis A. Genetic analysis of type-1 insulin-like growth factor receptor signaling through insulin receptor substrate-1 and -2 in pancreatic beta cells. The Journal of Biological Chemistry. 285: 41044-50. PMID 20947509 DOI: 10.1074/Jbc.M110.144790  0.552
2010 Chang CL, Seo T, Du CB, Accili D, Deckelbaum RJ. n-3 Fatty acids decrease arterial low-density lipoprotein cholesterol delivery and lipoprotein lipase levels in insulin-resistant mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 30: 2510-7. PMID 20930167 DOI: 10.1161/Atvbaha.110.215848  0.381
2010 Haeusler RA, Kaestner KH, Accili D. FoxOs function synergistically to promote glucose production. The Journal of Biological Chemistry. 285: 35245-8. PMID 20880840 DOI: 10.1074/Jbc.C110.175851  0.505
2010 Haeusler RA, Han S, Accili D. Hepatic FoxO1 ablation exacerbates lipid abnormalities during hyperglycemia. The Journal of Biological Chemistry. 285: 26861-8. PMID 20573950 DOI: 10.1074/Jbc.M110.134023  0.466
2010 Qiang L, Banks AS, Accili D. Uncoupling of acetylation from phosphorylation regulates FoxO1 function independent of its subcellular localization. The Journal of Biological Chemistry. 285: 27396-401. PMID 20519497 DOI: 10.1074/Jbc.M110.140228  0.32
2010 Ren H, Accili D, Duan C. Hypoxia converts the myogenic action of insulin-like growth factors into mitogenic action by differentially regulating multiple signaling pathways. Proceedings of the National Academy of Sciences of the United States of America. 107: 5857-62. PMID 20231451 DOI: 10.1073/Pnas.0909570107  0.384
2010 Nandi A, Wang X, Accili D, Wolgemuth DJ. The effect of insulin signaling on female reproductive function independent of adiposity and hyperglycemia. Endocrinology. 151: 1863-71. PMID 20176725 DOI: 10.1210/En.2009-0788  0.438
2010 Tabas I, Tall A, Accili D. The impact of macrophage insulin resistance on advanced atherosclerotic plaque progression. Circulation Research. 106: 58-67. PMID 20056946 DOI: 10.1161/Circresaha.109.208488  0.506
2010 Lin HV, Plum L, Ono H, Gutiérrez-Juárez R, Shanabrough M, Borok E, Horvath TL, Rossetti L, Accili D. Divergent regulation of energy expenditure and hepatic glucose production by insulin receptor in agouti-related protein and POMC neurons. Diabetes. 59: 337-46. PMID 19933998 DOI: 10.2337/Db09-1303  0.517
2009 Talchai C, Lin HV, Kitamura T, Accili D. Genetic and biochemical pathways of beta-cell failure in type 2 diabetes. Diabetes, Obesity & Metabolism. 11: 38-45. PMID 19817787 DOI: 10.1111/J.1463-1326.2009.01115.X  0.784
2009 Plum L, Lin HV, Dutia R, Tanaka J, Aizawa KS, Matsumoto M, Kim AJ, Cawley NX, Paik JH, Loh YP, DePinho RA, Wardlaw SL, Accili D. The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake. Nature Medicine. 15: 1195-201. PMID 19767734 DOI: 10.1038/Nm.2026  0.325
2009 Kitamura T, Kitamura YI, Kobayashi M, Kikuchi O, Sasaki T, Depinho RA, Accili D. Regulation of pancreatic juxtaductal endocrine cell formation by FoxO1. Molecular and Cellular Biology. 29: 4417-30. PMID 19506018 DOI: 10.1128/Mcb.01622-08  0.432
2009 Han S, Liang CP, Westerterp M, Senokuchi T, Welch CL, Wang Q, Matsumoto M, Accili D, Tall AR. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice. The Journal of Clinical Investigation. 119: 1029-41. PMID 19273907 DOI: 10.1172/Jci36523  0.467
2009 Accili D, Cola GD, Young Lee C, Cool MH. S-3: Metabolic abnormalities in mice lacking insulin receptors Experimental and Clinical Endocrinology & Diabetes. 104: 3-4. DOI: 10.1055/s-0029-1211489  0.368
2008 Banks AS, Kon N, Knight C, Matsumoto M, Gutiérrez-Juárez R, Rossetti L, Gu W, Accili D. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metabolism. 8: 333-41. PMID 18840364 DOI: 10.1016/J.Cmet.2008.08.014  0.53
2008 Senokuchi T, Liang CP, Seimon TA, Han S, Matsumoto M, Banks AS, Paik JH, DePinho RA, Accili D, Tabas I, Tall AR. Forkhead transcription factors (FoxOs) promote apoptosis of insulin-resistant macrophages during cholesterol-induced endoplasmic reticulum stress. Diabetes. 57: 2967-76. PMID 18728232 DOI: 10.2337/Db08-0520  0.421
2008 Haeusler RA, Accili D. The double life of Irs. Cell Metabolism. 8: 7-9. PMID 18590687 DOI: 10.1016/J.Cmet.2008.06.010  0.44
2008 Leroith D, Accili D. Mechanisms of disease: using genetically altered mice to study concepts of type 2 diabetes. Nature Clinical Practice. Endocrinology & Metabolism. 4: 164-72. PMID 18212763 DOI: 10.1038/Ncpendmet0729  0.503
2008 Goldfine ID, Maddux BA, Youngren JF, Reaven G, Accili D, Trischitta V, Vigneri R, Frittitta L. The role of membrane glycoprotein plasma cell antigen 1/ectonucleotide pyrophosphatase phosphodiesterase 1 in the pathogenesis of insulin resistance and related abnormalities. Endocrine Reviews. 29: 62-75. PMID 18199690 DOI: 10.1210/Er.2007-0004  0.546
2008 Accili D. PL9 Regulation of pancreatic endocrine function by IGF and insulin signalling Growth Hormone & Igf Research. 18: S19. DOI: 10.1016/S1096-6374(08)70062-5  0.39
2008 Accili D. Mechanisms of β cell failure in the pathogenesis of Type 2 diabetes Drug Development Research. 69: 111-115. DOI: 10.1002/Ddr.20234  0.52
2007 Tabas I, Seimon T, Arellano J, Li Y, Forcheron F, Cui D, Han S, Liang CP, Tall A, Accili D. The impact of insulin resistance on macrophage death pathways in advanced atherosclerosis. Novartis Foundation Symposium. 286: 99-109; discussion 1. PMID 18269177 DOI: 10.1002/9780470985571.Ch9  0.46
2007 Matsumoto M, Pocai A, Rossetti L, Depinho RA, Accili D. Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. Cell Metabolism. 6: 208-16. PMID 17767907 DOI: 10.1016/J.Cmet.2007.08.006  0.54
2007 Lin HV, Kim JY, Pocai A, Rossetti L, Shapiro L, Scherer PE, Accili D. Adiponectin resistance exacerbates insulin resistance in insulin receptor transgenic/knockout mice. Diabetes. 56: 1969-76. PMID 17475934 DOI: 10.2337/Db07-0127  0.559
2007 Adachi M, Osawa Y, Uchinami H, Kitamura T, Accili D, Brenner DA. The forkhead transcription factor FoxO1 regulates proliferation and transdifferentiation of hepatic stellate cells. Gastroenterology. 132: 1434-46. PMID 17408630 DOI: 10.1053/J.Gastro.2007.01.033  0.328
2007 Naïmi M, Gautier N, Chaussade C, Valverde AM, Accili D, Van Obberghen E. Nuclear forkhead box O1 controls and integrates key signaling pathways in hepatocytes. Endocrinology. 148: 2424-34. PMID 17303659 DOI: 10.1210/En.2006-1411  0.384
2007 Kim JJ, Kido Y, Scherer PE, White MF, Accili D. Analysis of compensatory beta-cell response in mice with combined mutations of Insr and Irs2. American Journal of Physiology. Endocrinology and Metabolism. 292: E1694-701. PMID 17299086 DOI: 10.1152/Ajpendo.00430.2006  0.532
2007 Buteau J, Shlien A, Foisy S, Accili D. Metabolic diapause in pancreatic beta-cells expressing a gain-of-function mutant of the forkhead protein Foxo1. The Journal of Biological Chemistry. 282: 287-93. PMID 17107961 DOI: 10.1074/Jbc.M606118200  0.456
2006 Matsumoto M, Han S, Kitamura T, Accili D. Dual role of transcription factor FoxO1 in controlling hepatic insulin sensitivity and lipid metabolism. The Journal of Clinical Investigation. 116: 2464-72. PMID 16906224 DOI: 10.1172/Jci27047  0.539
2006 Buteau J, Spatz ML, Accili D. Transcription factor FoxO1 mediates glucagon-like peptide-1 effects on pancreatic beta-cell mass. Diabetes. 55: 1190-6. PMID 16644672 DOI: 10.2337/Db05-0825  0.408
2006 Han S, Liang CP, DeVries-Seimon T, Ranalletta M, Welch CL, Collins-Fletcher K, Accili D, Tabas I, Tall AR. Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metabolism. 3: 257-66. PMID 16581003 DOI: 10.1016/J.Cmet.2006.02.008  0.511
2006 Okamoto H, Hribal ML, Lin HV, Bennett WR, Ward A, Accili D. Role of the forkhead protein FoxO1 in beta cell compensation to insulin resistance. The Journal of Clinical Investigation. 116: 775-82. PMID 16485043 DOI: 10.1172/Jci24967  0.733
2006 Maddux BA, Chang YN, Accili D, McGuinness OP, Youngren JF, Goldfine ID. Overexpression of the insulin receptor inhibitor PC-1/ENPP1 induces insulin resistance and hyperglycemia. American Journal of Physiology. Endocrinology and Metabolism. 290: E746-9. PMID 16278247 DOI: 10.1152/Ajpendo.00298.2005  0.556
2005 Federici M, Hribal ML, Menghini R, Kanno H, Marchetti V, Porzio O, Sunnarborg SW, Rizza S, Serino M, Cunsolo V, Lauro D, Mauriello A, Smookler DS, Sbraccia P, Sesti G, ... ... Accili D, et al. Timp3 deficiency in insulin receptor-haploinsufficient mice promotes diabetes and vascular inflammation via increased TNF-alpha. The Journal of Clinical Investigation. 115: 3494-505. PMID 16294222 DOI: 10.1172/Jci26052  0.502
2005 Kitamura YI, Kitamura T, Kruse JP, Raum JC, Stein R, Gu W, Accili D. FoxO1 protects against pancreatic beta cell failure through NeuroD and MafA induction. Cell Metabolism. 2: 153-63. PMID 16154098 DOI: 10.1016/J.Cmet.2005.08.004  0.447
2005 Banks AS, Li J, McKeag L, Hribal ML, Kashiwada M, Accili D, Rothman PB. Deletion of SOCS7 leads to enhanced insulin action and enlarged islets of Langerhans. The Journal of Clinical Investigation. 115: 2462-71. PMID 16127460 DOI: 10.1172/Jci23853  0.586
2005 Matsumoto M, Accili D. All roads lead to FoxO. Cell Metabolism. 1: 215-6. PMID 16054064 DOI: 10.1016/J.Cmet.2005.03.008  0.304
2005 Okamoto H, Obici S, Accili D, Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. The Journal of Clinical Investigation. 115: 1314-22. PMID 15864351 DOI: 10.1172/Jci23096  0.765
2005 Frescas D, Valenti L, Accili D. Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. The Journal of Biological Chemistry. 280: 20589-95. PMID 15788402 DOI: 10.1074/Jbc.M412357200  0.32
2005 Dong H, Maddux BA, Altomonte J, Meseck M, Accili D, Terkeltaub R, Johnson K, Youngren JF, Goldfine ID. Increased hepatic levels of the insulin receptor inhibitor, PC-1/NPP1, induce insulin resistance and glucose intolerance. Diabetes. 54: 367-72. PMID 15677494 DOI: 10.2337/Diabetes.54.2.367  0.539
2004 Okamoto H, Nakae J, Kitamura T, Park BC, Dragatsis I, Accili D. Transgenic rescue of insulin receptor-deficient mice. The Journal of Clinical Investigation. 114: 214-23. PMID 15254588 DOI: 10.1172/Jci21645  0.772
2004 Accili D. Lilly lecture 2003: the struggle for mastery in insulin action: from triumvirate to republic. Diabetes. 53: 1633-42. PMID 15220184 DOI: 10.2337/Diabetes.53.7.1633  0.596
2004 Accili D, Arden KC. FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell. 117: 421-6. PMID 15137936 DOI: 10.1016/S0092-8674(04)00452-0  0.328
2004 Tsuchida A, Yamauchi T, Ito Y, Hada Y, Maki T, Takekawa S, Kamon J, Kobayashi M, Suzuki R, Hara K, Kubota N, Terauchi Y, Froguel P, Nakae J, Kasuga M, ... Accili D, et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. The Journal of Biological Chemistry. 279: 30817-22. PMID 15123605 DOI: 10.1074/Jbc.M402367200  0.52
2004 Nandi A, Kitamura Y, Kahn CR, Accili D. Mouse models of insulin resistance. Physiological Reviews. 84: 623-47. PMID 15044684 DOI: 10.1152/Physrev.00032.2003  0.512
2004 Kitamura Y, Accili D. New insights into the integrated physiology of insulin action. Reviews in Endocrine & Metabolic Disorders. 5: 143-9. PMID 15041790 DOI: 10.1023/B:Remd.0000021436.91347.93  0.484
2004 Liang CP, Han S, Okamoto H, Carnemolla R, Tabas I, Accili D, Tall AR. Increased CD36 protein as a response to defective insulin signaling in macrophages. The Journal of Clinical Investigation. 113: 764-73. PMID 14991075 DOI: 10.1172/Jci19528  0.742
2004 Kitamura T, Kitamura Y, Nakae J, Giordano A, Cinti S, Kahn CR, Efstratiadis A, Accili D. Mosaic analysis of insulin receptor function. The Journal of Clinical Investigation. 113: 209-19. PMID 14722613 DOI: 10.1172/Jci17810  0.558
2003 Nef S, Verma-Kurvari S, Merenmies J, Vassalli JD, Efstratiadis A, Accili D, Parada LF. Testis determination requires insulin receptor family function in mice. Nature. 426: 291-5. PMID 14628051 DOI: 10.1038/Nature02059  0.419
2003 Hribal ML, Nakae J, Kitamura T, Shutter JR, Accili D. Regulation of insulin-like growth factor-dependent myoblast differentiation by Foxo forkhead transcription factors. The Journal of Cell Biology. 162: 535-41. PMID 12925703 DOI: 10.1083/Jcb.200212107  0.431
2003 Okamoto H, Accili D. In vivo mutagenesis of the insulin receptor. The Journal of Biological Chemistry. 278: 28359-62. PMID 12788928 DOI: 10.1074/Jbc.R300009200  0.764
2003 Altomonte J, Richter A, Harbaran S, Suriawinata J, Nakae J, Thung SN, Meseck M, Accili D, Dong H. Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice. American Journal of Physiology. Endocrinology and Metabolism. 285: E718-28. PMID 12783775 DOI: 10.1152/Ajpendo.00156.2003  0.521
2003 Puigserver P, Rhee J, Donovan J, Walkey CJ, Yoon JC, Oriente F, Kitamura Y, Altomonte J, Dong H, Accili D, Spiegelman BM. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction. Nature. 423: 550-5. PMID 12754525 DOI: 10.1038/Nature01667  0.467
2003 Nakae J, Kitamura T, Kitamura Y, Biggs WH, Arden KC, Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Developmental Cell. 4: 119-29. PMID 12530968 DOI: 10.1016/S1534-5807(02)00401-X  0.455
2003 Kim JJ, Accili D. Signalling through IGF-I and insulin receptors: where is the specificity? Growth Hormone & Igf Research : Official Journal of the Growth Hormone Research Society and the International Igf Research Society. 12: 84-90. PMID 12175645 DOI: 10.1054/Ghir.2002.0265  0.497
2003 Shahn Z, Okamoto H, Accili D, Deckelbaum R, Seo T. 2P-0429 Insulin resistant mice have an atherogenic plasma lipid profile and increased macrophage lipid uptake and deposition Atherosclerosis Supplements. 4: 133. DOI: 10.1016/S1567-5688(03)90571-X  0.3
2002 Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH, Wright CV, White MF, Arden KC, Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. The Journal of Clinical Investigation. 110: 1839-47. PMID 12488434 DOI: 10.1172/Jci16857  0.493
2002 Kitamura T, Kahn CR, Accili D. Insulin receptor knockout mice. Annual Review of Physiology. 65: 313-32. PMID 12471165 DOI: 10.1146/Annurev.Physiol.65.092101.142540  0.556
2002 Xuan S, Kitamura T, Nakae J, Politi K, Kido Y, Fisher PE, Morroni M, Cinti S, White MF, Herrera PL, Accili D, Efstratiadis A. Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. The Journal of Clinical Investigation. 110: 1011-9. PMID 12370279 DOI: 10.1172/Jci15276  0.563
2002 Chin D, Oberfield SE, Silfen ME, McMahon DJ, Manibo AM, Accili D, Levine LS. Proinsulin in girls: relationship to obesity, hyperinsulinemia, and puberty. The Journal of Clinical Endocrinology and Metabolism. 87: 4673-7. PMID 12364457 DOI: 10.1210/Jc.2001-011535  0.482
2002 Nakae J, Biggs WH, Kitamura T, Cavenee WK, Wright CV, Arden KC, Accili D. Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1. Nature Genetics. 32: 245-53. PMID 12219087 DOI: 10.1038/Ng890  0.586
2002 Kido Y, Nakae J, Hribal ML, Xuan S, Efstratiadis A, Accili D. Effects of mutations in the insulin-like growth factor signaling system on embryonic pancreas development and beta-cell compensation to insulin resistance. The Journal of Biological Chemistry. 277: 36740-7. PMID 12101187 DOI: 10.1074/Jbc.M206314200  0.565
2002 Hribal ML, Oriente F, Accili D. Mouse models of insulin resistance. American Journal of Physiology. Endocrinology and Metabolism. 282: E977-81. PMID 11934661 DOI: 10.1152/ajpendo.00561.2001  0.502
2002 Accili D, Kido Y, Nakae J, Lauro D, Park BC. Genetics of type 2 diabetes: insight from targeted mouse mutants. Current Molecular Medicine. 1: 9-23. PMID 11899245 DOI: 10.2174/1566524013364040  0.487
2002 Mauvais-Jarvis F, Ueki K, Fruman DA, Hirshman MF, Sakamoto K, Goodyear LJ, Iannacone M, Accili D, Cantley LC, Kahn CR. Reduced expression of the murine p85alpha subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. The Journal of Clinical Investigation. 109: 141-9. PMID 11781359 DOI: 10.1172/Jci13305  0.575
2002 Nakae J, Kido Y, Accili D. Distinct and overlapping functions of insulin and IGF-I receptors. Endocrine Reviews. 22: 818-35. PMID 11739335 DOI: 10.1210/Edrv.22.6.0452  0.488
2002 Accili D. A kinase in the life of the beta cell. The Journal of Clinical Investigation. 108: 1575-6. PMID 11733550 DOI: 10.1172/Jci14454  0.543
2002 Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH, Wright CV, White MF, Arden KC, Accili D. The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic β cell growth Journal of Clinical Investigation. 110: 1839-1847. DOI: 10.1172/JCI200216857  0.391
2001 Nakae J, Kitamura T, Silver DL, Accili D. The forkhead transcription factor Foxo1 (Fkhr) confers insulin sensitivity onto glucose-6-phosphatase expression. The Journal of Clinical Investigation. 108: 1359-67. PMID 11696581 DOI: 10.1172/Jci12876  0.56
2001 Nakae J, Kitamura T, Ogawa W, Kasuga M, Accili D. Insulin regulation of gene expression through the forkhead transcription factor Foxo1 (Fkhr) requires kinases distinct from Akt. Biochemistry. 40: 11768-76. PMID 11570877 DOI: 10.1021/Bi015532M  0.458
2001 Kitamura T, Kido Y, Nef S, Merenmies J, Parada LF, Accili D. Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor. Molecular and Cellular Biology. 21: 5624-30. PMID 11463843 DOI: 10.1128/Mcb.21.16.5624-5630.2001  0.549
2001 Kim JJ, Park BC, Kido Y, Accili D. Mitogenic and metabolic effects of type I IGF receptor overexpression in insulin receptor-deficient hepatocytes. Endocrinology. 142: 3354-60. PMID 11459778 DOI: 10.1210/Endo.142.8.8332  0.498
2001 Spravchikov N, Sizyakov G, Gartsbein M, Accili D, Tennenbaum T, Wertheimer E. Glucose effects on skin keratinocytes: implications for diabetes skin complications. Diabetes. 50: 1627-35. PMID 11423485 DOI: 10.2337/Diabetes.50.7.1627  0.509
2001 Shefi-Friedman L, Wertheimer E, Shen S, Bak A, Accili D, Sampson SR. Increased IGFR activity and glucose transport in cultured skeletal muscle from insulin receptor null mice. American Journal of Physiology. Endocrinology and Metabolism. 281: E16-24. PMID 11404219 DOI: 10.1152/Ajpendo.2001.281.1.E16  0.473
2001 Nakae J, Kido Y, Accili D. Tissue-specific insulin resistance in type 2 diabetes: lessons from gene-targeted mice. Annals of Medicine. 33: 22-7. PMID 11310935 DOI: 10.3109/07853890109002056  0.537
2001 Kido Y, Nakae J, Accili D. Clinical review 125: The insulin receptor and its cellular targets. The Journal of Clinical Endocrinology and Metabolism. 86: 972-9. PMID 11238471 DOI: 10.1210/Jcem.86.3.7306  0.539
2001 Wertheimer E, Spravchikov N, Trebicz M, Gartsbein M, Accili D, Avinoah I, Nofeh-Moses S, Sizyakov G, Tennenbaum T. The regulation of skin proliferation and differentiation in the IR null mouse: implications for skin complications of diabetes. Endocrinology. 142: 1234-41. PMID 11181540 DOI: 10.1210/Endo.142.3.7988  0.477
2001 Accili D. New perspectives in diabetes research and treatment. Trends in Endocrinology and Metabolism: Tem. 11: 349-50. PMID 11042463 DOI: 10.1016/S1043-2760(00)00326-X  0.556
2001 Nakae J, Kido Y, Kitamura T, Accili D. Glucose homeostasis: lessons from knockout mice Current Opinion in Endocrinology & Diabetes. 8: 82-87. DOI: 10.1097/00060793-200104000-00005  0.406
2000 Rother KI, Accili D. Role of insulin receptors and IGF receptors in growth and development. Pediatric Nephrology (Berlin, Germany). 14: 558-61. PMID 10912518 DOI: 10.1007/s004670000351  0.324
2000 Caruso M, Miele C, Oliva A, Condorelli G, Oriente F, Riccardi G, Capaldo B, Fiory F, Accili D, Formisano P, Beguinot F. The IR1152 mutant insulin receptor selectively impairs insulin action in skeletal muscle but not in liver. Diabetes. 49: 1194-202. PMID 10909978 DOI: 10.2337/diabetes.49.7.1194  0.447
2000 Hribal ML, Federici M, Porzio O, Lauro D, Borboni P, Accili D, Lauro R, Sesti G. The Gly-->Arg972 amino acid polymorphism in insulin receptor substrate-1 affects glucose metabolism in skeletal muscle cells. The Journal of Clinical Endocrinology and Metabolism. 85: 2004-2013. PMID 10843189 DOI: 10.1210/Jcem.85.5.6608  0.497
2000 Draznin B, Miles P, Kruszynska Y, Olefsky J, Friedman J, Golovchenko I, Stjernholm R, Wall K, Reitman M, Accili D, Cooksey R, McClain D, Goalstone M. Effects of insulin on prenylation as a mechanism of potentially detrimental influence of hyperinsulinemia. Endocrinology. 141: 1310-6. PMID 10746633 DOI: 10.1210/Endo.141.4.7411  0.468
2000 Tomizawa M, Kumar A, Perrot V, Nakae J, Accili D, Rechler MM, Kumaro A. Insulin inhibits the activation of transcription by a C-terminal fragment of the forkhead transcription factor FKHR. A mechanism for insulin inhibition of insulin-like growth factor-binding protein-1 transcription. The Journal of Biological Chemistry. 275: 7289-95. PMID 10702299 DOI: 10.1074/JBC.275.10.7289  0.361
2000 Nakae J, Barr V, Accili D. Differential regulation of gene expression by insulin and IGF-1 receptors correlates with phosphorylation of a single amino acid residue in the forkhead transcription factor FKHR. The Embo Journal. 19: 989-96. PMID 10698940 DOI: 10.1093/Emboj/19.5.989  0.455
2000 Lauro D, Kido Y, Hayashi H, Ebina Y, Accili D. Expression of kinase-inactive mutant insulin receptors does not rescue insulin receptor-deficient mice from perinatal death. Diabetologia. 42: 1441-2. PMID 10651265 DOI: 10.1007/s001250051318  0.4
2000 Kido Y, Burks DJ, Withers D, Bruning JC, Kahn CR, White MF, Accili D. Tissue-specific insulin resistance in mice with mutations in the insulin receptor, IRS-1, and IRS-2 Journal of Clinical Investigation. 105: 199-205. PMID 10642598 DOI: 10.1172/Jci7917  0.55
1999 Porzio O, Federici M, Hribal ML, Lauro D, Accili D, Lauro R, Borboni P, Sesti G. The Gly972-->Arg amino acid polymorphism in IRS-1 impairs insulin secretion in pancreatic beta cells. The Journal of Clinical Investigation. 104: 357-64. PMID 10430617 DOI: 10.1172/Jci5870  0.57
1999 Park BC, Kido Y, Accili D. Differential signaling of insulin and IGF-1 receptors to glycogen synthesis in murine hepatocytes. Biochemistry. 38: 7517-23. PMID 10360949 DOI: 10.1021/Bi9830718  0.52
1999 Nakae J, Park BC, Accili D. Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. The Journal of Biological Chemistry. 274: 15982-5. PMID 10347145 DOI: 10.1074/JBC.274.23.15982  0.391
1998 Brüning JC, Michael MD, Winnay JN, Hayashi T, Hörsch D, Accili D, Goodyear LJ, Kahn CR. A muscle-specific insulin receptor knockout exhibits features of the metabolic syndrome of NIDDM without altering glucose tolerance Molecular Cell. 2: 559-569. PMID 9844629 DOI: 10.1016/S1097-2765(00)80155-0  0.438
1998 Lauro D, Kido Y, Castle AL, Zarnowski MJ, Hayashi H, Ebina Y, Accili D. Impaired glucose tolerance in mice with a targeted impairment of insulin action in muscle and adipose tissue. Nature Genetics. 20: 294-8. PMID 9806552 DOI: 10.1038/3112  0.486
1998 Goalstone ML, Leitner JW, Wall K, Dolgonos L, Rother KI, Accili D, Draznin B. Effect of insulin on farnesyltransferase. Specificity of insulin action and potentiation of nuclear effects of insulin-like growth factor-1, epidermal growth factor, and platelet-derived growth factor. The Journal of Biological Chemistry. 273: 23892-6. PMID 9727002 DOI: 10.1074/JBC.273.37.23892  0.436
1998 Yu S, Yu D, Lee E, Eckhaus M, Lee R, Corria Z, Accili D, Westphal H, Weinstein LS. Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proceedings of the National Academy of Sciences of the United States of America. 95: 8715-20. PMID 9671744 DOI: 10.1073/Pnas.95.15.8715  0.31
1998 Rother KI, Imai Y, Caruso M, Beguinot F, Formisano P, Accili D. Evidence that IRS-2 phosphorylation is required for insulin action in hepatocytes. The Journal of Biological Chemistry. 273: 17491-7. PMID 9651339 DOI: 10.1074/JBC.273.28.17491  0.424
1998 Salvatore P, Hanash CR, Kido Y, Imai Y, Accili D. Identification of sirm, a novel insulin-regulated SH3 binding protein that associates with Grb-2 and FYN. The Journal of Biological Chemistry. 273: 6989-97. PMID 9507006 DOI: 10.1074/jbc.273.12.6989  0.466
1998 Cinti S, Eberbach S, Castellucci M, Accili D. Lack of insulin receptors affects the formation of white adipose tissue in mice. A morphometric and ultrastructural analysis. Diabetologia. 41: 171-7. PMID 9498650 DOI: 10.1007/s001250050886  0.43
1997 Brüning JC, Winnay J, Bonner-Weir S, Taylor SI, Accili D, Kahn CR. Development of a novel polygenic model of NIDDM in mice heterozygous for IR and IRS-1 null alleles Cell. 88: 561-572. PMID 9038347 DOI: 10.1016/S0092-8674(00)81896-6  0.503
1996 Jui HY, Accili D, Taylor SI. Characterization of a hybrid receptor formed by dimerization of the insulin receptor-related receptor (IRR) with the insulin receptor (IR): Coexpression of cDNAs encoding human IRR and human IR in NIH-3T3 cells Biochemistry. 35: 14326-14330. PMID 8916919 DOI: 10.1021/Bi9613032  0.484
1996 Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI, Westphal H. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene Nature Genetics. 12: 106-109. PMID 8528241 DOI: 10.1038/Ng0196-106  0.477
1995 Voliovitch H, Schindler DG, Hadari YR, Taylor SI, Accili D, Zick Y. Tyrosine phosphorylation of insulin receptor substrate-1 in vivo depends upon the presence of its pleckstrin homology region. The Journal of Biological Chemistry. 270: 18083-7. PMID 7629118 DOI: 10.1074/Jbc.270.30.18083  0.314
1995 Najjar SM, Philippe N, Suzuki Y, Ignacio GA, Formisano P, Accili D, Taylor SI. Insulin-stimulated phosphorylation of recombinant pp120/HA4, an endogenous substrate of the insulin receptor tyrosine kinase. Biochemistry. 34: 9341-9. PMID 7626603 DOI: 10.1021/Bi00029A009  0.437
1995 Formisano P, Najjar SM, Gross CN, Philippe N, Oriente F, Kern-Buell CL, Accili D, Gorden P. Receptor-mediated internalization of insulin. Potential role of pp120/HA4, a substrate of the insulin receptor kinase. The Journal of Biological Chemistry. 270: 24073-7. PMID 7592607 DOI: 10.1074/jbc.270.41.24073  0.423
1994 Taylor SI, Accili D, Haft CR, Hone J, Imai Y, Levy-Toledano R, Quon MJ, Suzuki Y, Wertheimer E. Mechanisms of hormone resistance: lessons from insulin-resistant patients Acta Paediatrica (Oslo, Norway : 1992). Supplement. 399: 95-104. PMID 7949626 DOI: 10.1111/J.1651-2227.1994.Tb13300.X  0.372
1994 Taylor SI, Accili D. The structure and function of insulin receptors Current Opinion in Endocrinology and Diabetes. 1: 231-238. DOI: 10.1097/00060793-199400010-00042  0.463
1993 Levy-Toledano R, Accili D, Taylor SI. Deletion of C-terminal 113 amino acids impairs processing and internalization of human insulin receptor: Comparison of receptors expressed in CHO and NIH-3T3 cells Bba - Molecular Cell Research. 1220: 1-14. PMID 8268238 DOI: 10.1016/0167-4889(93)90090-C  0.418
1993 Najjar SM, Philippe N, Taylor SI, Accili D. Molecular cloning of pp120/ ecto-ATPase, an endogenous substrate of the insulin receptor kinase Advances in Experimental Medicine and Biology. 343: 169-174. PMID 8184737 DOI: 10.1007/978-1-4615-2988-0_17  0.378
1992 Taylor SI, Cama A, Accili D, Barbetti F, Quon MJ, De La Luz Sierra M, Suzuki Y, Koller E, Levy-Toledano R, Wertheimer E, Moncada VY, Kadowaki H, Kadowaki T. Mutations in the insulin receptor gene Endocrine Reviews. 13: 566-595. PMID 1330507 DOI: 10.1210/Edrv-13-3-566  0.409
1991 Taylor SI, Accili D, Cama A, Imano E, Kadowaki H, Kadowaki T. Unusual forms of insulin resistance Annual Review of Medicine. 42: 373-379. PMID 2035982 DOI: 10.1146/Annurev.Me.42.020191.002105  0.538
1991 Taylor SI, Cama A, Accili D, Barbetti F, Imano E, Kadowaki H, Kadowaki T. Genetic basis of endocrine disease 1: Molecular genetics of insulin resistant diabetes mellitus Journal of Clinical Endocrinology and Metabolism. 73: 1158-1163. PMID 1955495 DOI: 10.1210/Jcem-73-6-1158  0.55
1990 Barbetti F, Raben N, Kadowaki T, Cama A, Accili D, Gabbay KH, Merenich JA, Taylor SI, Roth J. Two unrelated patients with familial hyperproinsulinemia due to a mutation substituting histidine for arginine at position 65 in the proinsulin molecule: Identification of the mutation by direct sequencing of genomic deoxyribonucleic acid amplified by polymerase chain reaction Journal of Clinical Endocrinology and Metabolism. 71: 164-169. PMID 2196279 DOI: 10.1210/Jcem-71-1-164  0.424
1990 Taylor SI, Cama A, Kadowaki H, Kadowaki T, Accili D. Mutations of the human insulin receptor gene Trends in Endocrinology and Metabolism. 1: 134-139. DOI: 10.1016/1043-2760(90)90024-W  0.389
1989 Odawara M, Kadowaki T, Yamamoto R, Shibasaki Y, Tobe K, Accili D, Bevins C, Mikami Y, Matsuura N, Akanuma Y, Takaku F, Taylor SI, Kasuga M. Human diabetes associated with a mutation in the tyrosine kinase domain of the insulin receptor Science. 245: 66-68. PMID 2544998 DOI: 10.1126/science.2544998  0.307
1989 Taylor SI, Barbetti F, Accili D, Roth J, Gorden P. Syndromes of Autoimmunity and Hypoglycemia: Autoantibodies Directed Against insulinand Its Receptor Endocrinology and Metabolism Clinics of North America. 18: 123-143. DOI: 10.1016/S0889-8529(18)30392-X  0.515
1987 Perrotti N, Accili D, Marcus-Samuels B, Rees-Jones RW, Taylor SI. Insulin stimulates phosphorylation of a 120-kDa glycoprotein substrate (pp120) for the receptor-associated protein kinase in intact H-35 hepatoma cells. Proceedings of the National Academy of Sciences of the United States of America. 84: 3137-40. PMID 3033636 DOI: 10.1073/Pnas.84.10.3137  0.433
1986 Accili D, Perrotti N, Rees-Jones R, Taylor SI. Tissue distribution and subcellular localization of an endogenous substrate (pp 120) for the insulin receptor-associated tyrosine kinase. Endocrinology. 119: 1274-80. PMID 3015574 DOI: 10.1210/Endo-119-3-1274  0.374
Show low-probability matches.